Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06137339 · ClinicalTrials.gov registry record · NA
AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults
A NA study of Brain Aging, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06137339: Recruiting NA study of Brain Aging, sponsored by University of Kansas Medical Center.
NCT06137339 is a NA study of Brain Aging that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 70 participants, below the 256-participant average among 3 other Brain Aging trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06137339, a NA study of Brain Aging, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to determine if adding avocados to the diet of impacts cognition in 70 older adults, age 65-85, without dementia. We will test for change in functional MRI, cognitive performance, and brain blood flow. Intervention group participants will be asked to consume 1 avocado per day for 12 weeks. Participants in the control group will be asked to continue their normal intake for 12 weeks. Throughout the study, participants will be asked to perform cognitive tests, MRI, blood tests, and questionnaires.
Conditions Studied
Interventions
- OTHER Avocado Group
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-04-09 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06137339 shows while recruiting
NCT06137339 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 256-participant average among 3 other Brain Aging trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Brain Aging appearing as the primary indexed condition, and to 1 intervention - of which Avocado Group is the first listed.
NCT06137339 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT06137339 about?
NCT06137339 is a clinical study titled "AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults". The goal of this clinical trial is to determine if adding avocados to the diet of impacts cognition in 70 older adults, age 65-85, without dementia. We will test for change in functional MRI, cognitive performance, and brain blood flow. Intervention group participants will be asked to consume 1 avoc...
What is the current status of trial NCT06137339?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-04-09. Estimated completion is 2025-12.
What conditions does trial NCT06137339 study?
This clinical trial studies the following conditions: Brain Aging.
What interventions are being tested in trial NCT06137339?
The interventions under investigation include: Avocado Group (OTHER).
Who is sponsoring clinical trial NCT06137339?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06137339 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI